Condition: Amblyopia · Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University
This prospective study aims to observe the predictive effect of peripheral blood plasma biomarker on the outcome of treatment in children with different types of amblyopia. We also investigated the mechanism of neuromodulation in the visual development of amblyopic children.
This description comes directly from the study's public registry record.
Jinrong Li, PhD · 86-020-87330351 · lijingr3@mail.sysu.edu.cn
Always discuss trial participation with your own doctor first.
| Zhongshan Ophthalmic Center | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05705778